Search

2D transition metal dichalcogenides (TMDs) for advanced logic transistor technologies are deposited by various modifications of the chemical vapor deposition (CVD) method using a wide variety of precursors. Being a major electrical performance limiter, the TMD crystal grain size strongly differs between the various CVD precursor chemistries from nano‐ to millimeter‐sized crystals. However, it remains unclear how the CVD precursor chemistry affects the nucleation density and resulting TMD crystal grain size. This work postulates guiding principles to design a CVD process for highly crystalline TMD deposition using a quantitative analytical model benchmarked against the literature. The TMD nucleation density reduces favorably under low supersaturation conditions where the metal precursor sorption on the starting surface is reversible and the corresponding metal precursor desorption rate exceeds the overall deposition rate. Such reversible precursor adsorption guarantees efficient long‐range gas‐phase lateral diffusion of precursor species in addition to short‐range surface diffusion, which vitally increases crystal grain size. The proposed model explains the large spread in experimentally observed TMD nucleation densities and crystal grain sizes for state‐of‐the‐art CVD chemistries. Ultimately, it empowers the reader to interpret and modulate precursor adsorption and diffusion reactions through designing CVD precursor chemistries. [ABSTRACT FROM AUTHOR]

While the power conversion efficiency (PCE) of organic photovoltaics (OPV) on small‐area lab cells has rapidly increased during the last few years, the performance on module level and the availability of OPV modules on the market is still limited, primarily due to specific constraints imposed by the industrial production process. This work deals with the upscaling process of latest‐generation OPV from small‐area lab cells to fully solution‐processed modules, which are compatible to industrial roll‐to‐roll (R2R) printing. This transfer is demonstrated step by step from material selection and process optimization for every single layer of the stack (photoactive layer, charge transporting layers, and solution‐processed top electrode)–including long‐term stability investigations (thermal and light)–to scaling up the device area by a factor of >100. Thus, a semitransparent OPV module with 10.8% PCE on 10.2 cm2 active area is achieved, which is among the highest performances for semitransparent, fully solution‐processed OPV modules. The individual developments all meet the requirements for industrial R2R printing (green solvents, processing in air, annealing ≤140 °C, etc.), which ensures that both the optimized layer stack and the fabrication process are fully scalable and easily transferable to large‐scale production. [ABSTRACT FROM AUTHOR]

The introduction of nonfullerene acceptors (NFAs) has pushed the power conversion efficiency and organic photovoltaics (OPV) device stability to new standards. In this aspect, removal of trace impurities from one purification stage to the next is frequently stressed throughout the synthesis of photoactive OPV materials and NFAs to obtain the highest‐purity material. However, detailed studies of the effect of purification on device performance are less reported. Herein, the role of NFA trace impurities on the optoelectronic characteristics and lifetime of resulting OPV devices is studied. The optimization of PBDB‐T:ITIC‐X devices, with various ITIC purity levels (X), has been thoroughly studied via a combination of photophysical, chemical, morphological, electrical, and optical characterization techniques, to shine light on the role of these impurities on device performance and lifetime. The findings suggest that, even in materials with larger concentrations of trace impurities, careful tuning can produce high efficiencies. Interestingly, the less‐pure materials lead to longer device lifetimes along with an enhancement in accumulative power generation by a factor 3, compared to the purest ITIC‐based devices. This demonstrates that selecting a material with the highest purity may not always be the best option for NFA OPV and that any positive effects of NFA purification must be carefully considered in light of both the device efficiency and stability. [ABSTRACT FROM AUTHOR]

Background: Anti‐K is an alloantibody stimulated in response to the KEL1 antigen and may cause hemolytic disease of the fetus and newborn (HDFN). Provision of KEL1 negative blood to females of child‐bearing potential was not our practice. We assessed the impact of our policy and assessed feasibility of a KEL1 negative transfusion policy. Study design and methods: This is a cohort study spanning Jan 1, 2007–Jun 30, 2017 in Hamilton, Canada. Data were obtained via our institution's transfusion database. Chart reviews of females age ≤45 with anti‐K were performed; data on RBC KEL1 phenotype were obtained from the blood supplier when needed to ascertain the cause of alloimmunization. Descriptive analysis of hospital KEL1 negative inventory demand and supply was performed. Results: From Jan 2007‐Jun 2017, 8.6% of all RBC units transfused were provided to females age ≤45. There were 111 females with detectable anti‐K. Median age at time of antibody detection was 34 years (interquartile range 27–40) and 28 of 111 (25.2%) patients may have been alloimmunized by transfusion. Of 49 pregnancies, seven had complications due to anti‐K. We estimated that our existing RBC inventory (with 16% units known to be KEL1 negative in 2017) is sufficient to meet demand and support a KEL1 negative transfusion policy for females age ≤45. Conclusion: Transfusion was responsible for alloimmunization in 25% of females with anti‐K over 10 years. Analysis of supply and demand can be used to inform feasibility of a KEL1 negative transfusion policy. [ABSTRACT FROM AUTHOR]

Background and Objectives: A high proportion of suspected weak D patients referred to Héma‐Québec were genotyped as weak D type 42 (368/2105, 17.5%). These patients are currently considered D with regard to RhD immunoprophylaxis in pregnancy and transfusion. The goal of this study was to retrospectively evaluate the risk of alloimmunization in weak D type 42 patients and to characterize their RhD surface molecule expression on red blood cells (RBCs) in comparison to other weak D types (1, 2 and 3). Materials and Methods: A retrospective analysis using the weak D type 42 patients' medical data to verify potential anti‐D alloimmunization events was conducted. Quantitative analyses using flow cytometry were also performed on RBCs to quantify the cell surface density of the D antigen. Results: Data on 215 subjects with weak D type 42 were reviewed. None developed immune allo‐anti‐D; three had definite exposure to D+ red cells and 41 had possible exposure through pregnancy. Flow cytometry analysis showed that weak D types 1, 2, 3 and 42 had relative antigen densities of 2.7%, 2.2%, 8.1% and 3.6%, respectively, with R1R2 red cells referencing 100% density. The estimated antigen density range of weak D type 42 was 819–1104 sites per RBC. Conclusion: Our retrospective alloimmunization data analysis and antigen density study establish a basis for the consideration of a weak D type 42 individual as D+. This consideration would allow for a targeted reduction of RhD immunoprophylaxis in pregnancy and the unjustified use of D– units for transfusion. [ABSTRACT FROM AUTHOR]

Background: The efficacy of premedication for the prevention of nonhemolytic transfusion reactions remains controversial. This systematic review and meta-analysis assessed the effect of premedication on the rate of nonhemolytic transfusion reactions after allogeneic blood transfusion.Study Design and Methods: We searched the literature using CENTRAL, MEDLINE, EMBASE, ISI Web of Science, and clinicaltrials.gov databases from inception until October 31, 2018. We included all randomized controlled trials comparing premedication to placebo or no treatment in patients receiving any labile blood product. Outcome measures were reported as relative risks (RRs) with 95% confidence intervals (CIs). Data were combined for similar outcomes where appropriate using a random-effects model. Analyses were done at both the patient and transfusion level.Results: Three randomized trials using acetaminophen and antihistamine as premedication met the inclusion criteria. A total of 517 patients received 4444 red blood cell or platelet transfusions. Pooled patient-level estimates with premedication for all nonhemolytic, febrile nonhemolytic, and minor allergic reactions were RR, 0.92 (95% CI, 0.63-1.35); RR, 0.54 (95% CI, 0.26-1.1); and RR, 1.37 (95% CI 0.81-2.31), respectively. Transfusion-level analyses also showed no benefit with premedication. Of 517 patients randomized, only 27 (5.2%) had a history of transfusion reactions.Conclusion: Routine premedication with acetaminophen and antihistamines did not prevent nonhemolytic transfusion reactions; however, the estimate of effect was greatest for febrile reactions. The impact of premedication in patients with a prior history of transfusion reactions remains unknown and requires further evaluation in future clinical trials. [ABSTRACT FROM AUTHOR]

Background: Transfusion-associated anaphylaxis has been associated with anti-immunoglobulin A (anti-IgA) of IgG class in patients with IgA deficiency. In recent years, however, the frequency and clinical impact of this syndrome has been questioned. We present a case of recurrent red blood cell (RBC) transfusion-associated anaphylactoid reactions (rigors, hypertension, transient monocytopenia, and neutropenia) associated with anti-IgA.Case Report: An 88-year-old woman developed anemia after a traumatic right humerus fracture. After receiving approximately 100 mL of RBCs she developed rigors and hypertension; her absolute neutrophil and monocyte counts decreased by 73 and 100%, respectively. All symptoms and signs resolved, and her blood counts normalized. A second RBC transfusion was given, with recurrence of rigors, hypertension, neutropenia, and monocytopenia (69 and 100% declines, respectively), along with fever. All tests for hemolysis were negative. She then received two transfusions of washed RBCs, without incident. The patient was found to be deficient in IgA (<0.05 mg/dL). Further, anti-IgA of IgG class antibodies were detected in high levels by enzyme-linked immunosorbent assay (>1000 U/mL). We reviewed case reports, case series, and reviews of IgA deficiency-associated reactions, examining whether hypertensive reactions and acute neutropenia and/or monocytopenia have been associated with anti-IgA reactions.Results: Reports of reactions associated with anti-IgA emphasize hypotension and are generally classified as "anaphylactic or anaphylaxis." No previous reports described neutropenia or monocytopenia.Conclusion: Our case suggests that adverse transfusion reactions associated with anti-IgA of IgG class may sometimes be characterized by anaphylactoid features such as rigors and hypertension, with transient monocytopenia and neutropenia. [ABSTRACT FROM AUTHOR]

Tandem device architectures offer a route to greatly increase the maximum possible power conversion efficiencies (PCEs) of polymer solar cells, however, the complexity of tandem cell device fabrication (such as selecting bandgaps of the front and back cells, current matching, thickness, and recombination layer optimization) often result in lower PCEs than are observed in single‐junction devices. In this study, we analyze the influence of front cell and back cell bandgaps and use transfer matrix modeling to rationally design and optimize effective tandem solar cell structures before actual device fabrication. Our approach allows us to estimate tandem device parameters based on known absorption coefficients and open‐circuit voltages of different active layer materials and design devices without wasting valuable time and materials. Using this approach, we have investigated a series of wide bandgap, high voltage photovoltaic polymers as front cells in tandem devices with PTB7‐Th as a back cell. In this way, we have been able to demonstrate tandem devices with PCE of up to 12.8% with minimal consumption of valuable photoactive materials in tandem device optimization. This value represents one of the highest PCE values to date for fullerene‐based tandem solar cells. [ABSTRACT FROM AUTHOR]

A novel variant DO*A allele with a c.370delT mutation leading to a DO-null phenotype in a Syrian family The Dombrock antigens are clinically relevant blood group antigens, known for potentially causing delayed and acute hemolytic transfusion reactions, although no hemolytic disease of the fetus and newborn has been described.1,2 We report here a new DO allele in a family of Syrian origin caused by a c.370delT (p.Leu124Cys) nonsense mutation, leading to a DO-null phenotype (ISBT Allele Number I DO*01 N.05 i , GenBank Accession Number MT747635). In this report, we describe a novel I DO*A i allele (c.370delT [p.Leu124Cysfs*4]) involving a nonsense mutation, leading to absent expression of all Dombrock antigens or a DO-null phenotype. [Extracted from the article]

This article describes how information provided by the international community influences the design of training programs for airport security officers at the Canadian Air Transport Security Authority (CATSA). It explains how the integration of this information was instrumental in selecting a training program that follows the principles of a competency-based methodology. This review coincides with the fourth anniversary of the creation of CATSA and the fifth of the tragedy of September 11th, 2001. The authors identify major airport security issues, opportunities and constraints dictated by the international context, and the main strategic and methodological alternatives. [ABSTRACT FROM AUTHOR]

The social dimensions of health and illness have been studied extensively from a materialistic angle. The nonmaterial or subjective factors of social experience affecting health have only recently received some attention. This paper introduces a new multidimensional concept of rank, which includes social dimensions as well as nonmaterially based elements of emotional, psychological, and spiritual strength. It proposes that rank is an important addition to the current literature of socioeconomic inequality and health and examines its relevance for the discussion of how social status inequalities affect people's global health. It suggests that rank as a signifier of power contributes to feelings of powerlessness and leads to worsened health outcomes. This paper suggests that perceived rank may play a role in the socioeconomic status (SES) effect on self-reported health. It presents a new conceptual and therapeutic model to address issues of rank-based discrimination in health care. Copyright © 2006 John Wiley & Sons, Ltd. [ABSTRACT FROM AUTHOR]

The modification of cell surface lipids or proteins with sialic acid is essential for many biological processes and several diseases are caused by defective sialic acid metabolism. Sialic acids cleaved off from degraded sialoglycoconjugates are exported from lysosomes by a membrane transporter, named sialin, which is defective in two allelic inherited diseases: infantile sialic acid storage disease (ISSD) and Salla disease. To develop a functional assay of human sialin, we redirected the protein to the plasma membrane by mutating a dileucine-based internalization motif. Cells expressing the plasmalemmal construct accumulated neuraminic acid at acidic pH by a process equivalent to lysosomal efflux. The assay was used to determine how pathogenic mutations affect transport. Interestingly, while two missense mutations and one small, in-frame deletion associated with ISSD abolished transport, the mutation causing Salla disease (R39C) slowed down, but did not stop, the transport cycle, thus explaining why the latter disorder is less severe. Since neurological symptoms predominate in Salla disease, our results suggest that sialin is rate-limiting to specific sialic acid-dependent processes of the nervous system. [ABSTRACT FROM AUTHOR]

Background and Objectives Materials and Methods Results Conclusion Postpartum anaemia is a prevalent health problem. We aimed to determine the compliance rate for red blood cell (RBC) transfusion indication among postpartum women in a single tertiary care centre in Quebec, Canada.Retrospective cohort study including all women ≥6 h postpartum who received ≥1 RBC transfusion during their delivery hospitalization between January 2005 and February 2022. We determined our centre's compliance rate by indication as compared to current society guidelines, all published after 2015 (Network for the Advancement of Patient Blood Management, Haemostasis and Thrombosis [NATA], Royal College of Obstetricians and Gynaecologists [RCOG], American College of Obstetricians and Gynecologists [ACOG]). We then explored predictors of guideline non‐compliance and described transfusion practices in our centre.A total of 171 women were included. Our centre's compliance rate was 79.5% (95% confidence interval [CI] 72.7–84.8). Predictors of guideline non‐compliance were maternal medical comorbidity or abnormal placentation, both limited by large CIs (odds ratio [OR] 2.26, CI 1.02–4.94, p = 0.04; OR 4.00, CI 1.31–12.06, p = 0.01, respectively). Postpartum haemorrhage was diagnosed among 68% of the cohort, mostly due to uterine atony (73.3%). Mean baseline and nadir haemoglobin were 111 g/L (±18) and 62 g/L (±7.7), respectively. Multiple unit initial transfusion was found in a majority of patients (63.7%). Iron therapy was administered to 51.5% of women in‐hospital and 81.9% received an oral iron prescription at discharge. There were no differences in primary or secondary outcomes subsequent to relevant guideline publication.Our centre's compliance rate for RBC transfusion indication meets current practice guidelines. Areas for improvement include single‐unit initial transfusion protocols and adjuvant iron treatment. Antenatal optimization of haemoglobin and ferritin stores may limit postpartum transfusions. [ABSTRACT FROM AUTHOR]

Background Information: Free sialic acid storage diseases are caused by mutations of a lysosomal sialic acid transporter called sialin. We showed recently that the milder clinical form, Salla disease, and a related non-Finish case, are characterized by residual transport, whereas sialin mutants found in lethal infantile cases are inactive. In the present study, we have characterized the molecular effects of a putative polymorphism (M316I) and of four pathogenic mutations associated with either infantile (G127E and R57C) or Salla-like (G409E) phenotypes, or both (G328E). The transport activity of human sialin was analysed using a novel assay that was based on a construct without the functional lysosomal sorting motif, which is expressed at the plasma membrane., Results: The lysosomal localization of human sialin was not (M316I and G328E) or only partially (R57C, G127E and G409E) affected by the missense mutations. In contrast, all pathogenic mutations abolished transport, whereas the putative M316I polymorphism induced an approx. 5-fold decrease of sialic acid transport., Conclusions: The molecular effects of the R57C and G127E mutations strengthen the conclusion that the infantile phenotype is caused by loss-of-function mutations. On the other hand, the milder severity of the heterozygous G409E patient may reflect an incomplete expression of the splicing mutation present on the second allele. In the case of the G328E mutation, found in the homozygous state in a clinically heterogeneous family, the apparent severity of the transport phenotype suggests that the genetic or environmental factors underlying this clinical heterogeneity might be protective.